There are a lot of questions about prescription drugs.
We’ve talked about how they work, what they do, and how they interact with other medicines and drugs.
But there are also a lot more questions about how the pharmaceutical industry and the government get the drugs to work.
The pharmaceutical industry has long been a target for antitrust enforcement efforts.
But a recent study by researchers at MIT, Harvard, and Harvard Medical School found that pharmaceutical companies spend far more than other industries on lobbying.
The study, published this week in the journal Science, found that the industry spent $5.9 billion on lobbying in 2010, nearly twice as much as all other industries.
The industry also spends more than all other sectors combined on lobbying, which could explain why the drugs it’s lobbying for have a better track record.
It’s not a matter of pure economics.
The lobbying effort is all about politics, according to a former senior official with the Office of Government Ethics.
“In our view, the influence of the pharmaceutical sector is largely driven by the politics of pharmaceutical companies,” says John Donohue, the former ethics official who’s now a professor at the University of California, Irvine.
Donohoe also says that the lobbying has little to do with the science behind the drugs and is instead driven by political pressure.
“If you want to change a drug, you need to find a politician who will say ‘Yes, this drug can be made cheaper,'” he says.
“The pharmaceutical industry’s got this ability to find somebody who is willing to say ‘No, I can’t.’
That’s a big part of it.”
In 2010, the year the study was conducted, the top four pharmaceutical companies spent more than $3 billion on campaign contributions and lobbying.
This year, they spent more, and they’re expected to spend another $2 billion on election-year spending.
But in order to be successful in that effort, the pharmaceutical companies have to win the trust of regulators.
“You’ve got to have this trust that there’s a reason for the product, and that the people who are making that product understand it,” Donohu says.
That’s an uphill battle, especially when it comes to the flu vaccine, which is a major political issue in the United States.
The flu vaccine is a controversial product that has received a lot a lot since the pandemic.
Many Americans believe that it is safe and effective.
But the federal government has been unable to produce the vaccine on time and has had to spend millions on trial runs to prove its safety.
The current flu vaccine has been criticized for its lack of efficacy.
In fact, it has been linked to serious side effects.
The government recently began issuing new flu shots, but many of them are not being distributed to patients.
The new vaccine also has a longer duration of effectiveness, but that’s the big question.
Some people are concerned about the lack of flu shots in the US.
Others are worried about the increased use of the flu shot as the pandemics intensify.
Some scientists are concerned that some people who aren’t getting vaccinated might still have an illness.
“That’s going to be a real challenge,” Donahue says.
It also has the potential to affect the future of the influenza vaccine, because it’s a long-lasting vaccine.
The vaccine has also been criticized because it can cause serious side-effects.
The FDA has said that there is a risk of side-effect syndrome with the vaccine, but a few scientists have suggested that side effects might be milder in the long term.
The National Institutes of Health is also investigating side effects with the flu vaccines, and a study published in the Lancet this year showed that people who took flu shots had a higher risk of developing severe side effects, but they didn’t have higher rates of severe side-event.
“There’s no reason why the flu shots shouldn’t be given to everybody,” Donoye says.
The debate over flu vaccines isn’t limited to the US and other countries.
Many other countries are looking into whether they can make their own flu vaccines.
The United Kingdom is considering a similar vaccine, and the UK government says that it will consider a similar vaccination for other countries as well.
The US also has its own flu vaccine that is now in clinical trials, and its FDA is considering giving the vaccine to people with existing health problems, including people with chronic health conditions, who don’t need a new vaccine.
There’s also the issue of whether people should be allowed to buy flu shots themselves.
The Centers for Disease Control and Prevention estimates that the flu has killed over 13 million people worldwide since the start of the pandemia.
The CDC estimates that between 10 and 40 million people are expected to die this year due to the virus.
Donahues report found that in 2010 the average time from first diagnosis to flu shot use was 14 days.
The average time between first and last flu shot is 27 days.
If you live in a state that doesn’t have